Crohn's disease Trials in Durban, South Africa
Conditions / Crohn's disease / Durban, South Africa
Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00160524 | A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] | COMPLETED | PHASE3 |
| NCT01298492 | A Study To Monitor Long-Term Treatment With PF-00547659 | COMPLETED | PHASE2 |
| NCT05242471 | A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT01276509 | Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease | COMPLETED | PHASE2 |
| NCT02405442 | Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE2 |
| NCT00615199 | A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease | COMPLETED | PHASE2 |
| NCT01393626 | A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease | COMPLETED | PHASE2 |
| NCT07184931 | An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease | RECRUITING | — |
| NCT00195715 | Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease | COMPLETED | PHASE3 |
| NCT01369342 | A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2) | COMPLETED | PHASE3 |